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Endochondral Growth Defect and Deployment of Transient
Chondrocyte Behaviors Underlie Osteoarthritis Onset
in a Natural Murine Model
K. A. Staines,1 K. Madi,2 S. M. Mirczuk,3 S. Parker,3 A. Burleigh,3 B. Poulet,4 M. Hopkinson,3
A. J. Bodey,5 R. C. Fowkes,3 C. Farquharson,6 P. D. Lee,2 and A. A. Pitsillides3
Objective. To explore whether aberrant transient
chondrocyte behaviors occur in the joints of STR/Ort
mice (which spontaneously develop osteoarthritis [OA])
and whether they are attributable to an endochondral
growth defect.
Methods. Knee joints from STR/Ort mice with
advanced OA and age-matched CBA (control) mice were
examined by Affymetrix microarray profiling, multiplex
polymerase chain reaction (PCR) analysis, and immuno-
histochemical labeling of endochondral markers, includ-
ing sclerostin and MEPE. The endochondral phenotype
of STR/Ort mice was analyzed by histologic examination,
micro–computed tomography, and ex vivo organ culture.
A novel protocol for quantifying bony bridges across the
murine epiphysis (growth plate fusion) using synchro-
tron x-ray computed microtomography was developed
and applied.
Results. Meta-analysis of transcription profiles
showed significant elevation in functions linked with
endochondral ossification in STR/Ort mice (compared
to CBA mice; P < 0.05). Consistent with this, immuno-
labeling revealed increased matrix metalloproteinase
13 (MMP-13) and type X collagen expression in STR/
Ort mouse joints, and multiplex quantitative reverse
transcriptase–PCR showed differential expression of
known mineralization regulators, suggesting an inher-
ent chondrocyte defect. Support for the notion of an
endochondral defect included accelerated growth,
increased zone of growth plate proliferative chondro-
cytes (P < 0.05), and widespread type X collagen/MMP-
13 labeling beyond the expected hypertrophic zone dis-
tribution. OA development involved concomitant focal
suppression of sclerostin/MEPE in STR/Ort mice. Our
novel synchrotron radiation microtomography method
showed increased numbers (P < 0.001) and mean areal
growth plate bridge densities (P < 0.01) in young and
aged STR/Ort mice compared to age-matched CBA
mice.
Conclusion. Taken together, our data support
the notion of an inherent endochondral defect that is
linked to growth dynamics and subject to regulation by
the MEPE/sclerostin axis and may represent an under-
lying mechanism of pathologic ossification in OA.
Osteoarthritis (OA) is a degenerative joint disease
and a health care burden throughout the world. Charac-
terized by articular cartilage loss, subchondral bone thick-
ening, and osteophyte formation, OA causes much pain
and disability. Its underlying molecular mechanisms are,
nevertheless, not fully understood; indeed, even the pre-
cipitating pathology is still a matter of debate. As such,
there is an ever-growing need for an effective disease-
modifying treatment. Canine hip dysplasia is a hereditary
predisposition to the development of degenerative OA
and is more common in certain breeds, in particular
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larger breeds which tend to grow more rapidly (1). While
no direct link has been made between growth dynamics
and OA, recent murine and human studies have prompted
speculation that articular cartilage chondrocytes may
undergo a transition from their inherently stable pheno-
type to a more transient one characteristic of the chondro-
cytes in the growth plate (2–9).
The epiphyseal growth plates are responsible for
long bone development (endochondral ossification) and
growth, which is secured by growth plate chondrocytes
undergoing differentiation, maturation, hypertrophy, and
death, resulting in mineralization of the cartilage matrix
(10–13). Transience of growth plate cartilage chondrocytes
is thus a crucial attribute. However, this is in sharp con-
trast with the inherent stability of articular cartilage chon-
drocytes, in which these dynamic events must be restricted
to assure life long articular integrity and joint function.
Interlinks between these apparently discordant pheno-
types are not fully understood, and whether switching in
these behaviors may contribute to the structural demise of
articular cartilage in OA joints has not yet been estab-
lished (13–15). However, based on the common embryolo-
gy of cartilage and bone, along with recent evidence
supporting distinct origins of growth plate and articular car-
tilage chondrocytes, it is not surprising that this hypothesis
has been controversial (16–18). Regardless, an exploration
of the mechanisms controlling changes that chondrocytes
undergo during their transition through the various stages
of endochondral ossification may help to decipher those
that underlie pathologic ossification inOA.
The STR/Ort mouse is a well-established, natural
model of OA, with disease resembling that in humans.
Mice develop articular cartilage lesions on the medial
tibial plateau, with subchondral bone thickening and
expected degenerative changes in other joint tissues
beginning at ;18 weeks of age, coincident with attain-
ment of skeletal maturity (19–22). CBA mice, the clos-
est available parental strain, show, in contrast, very low
spontaneous OA susceptibility (21,23). We therefore
aimed to establish whether an aberrant deployment of
the transient chondrocyte phenotype is observed in
STR/Ort mouse joints and whether this can be attribut-
ed to modified growth dynamics underpinned by an
inherent endochondral growth defect.
MATERIALS AND METHODS
Animals. Male STR/Ort mice (bred in-house) and CBA
mice (Charles River) were used in all experiments. All procedures
complied with the Animals (Scientific Procedures) Act 1986 and
local ethics committee guidelines.
Meta-analysis of microarray data. Gene ontology
classification, on Affymetrix mouse gene microarray profiling
of articular cartilage that we had performed previously (22),
was carried out using DAVID (http://david.abcc.ncifcrf.gov/)
(24).
RNA extraction. RNA was extracted from the knee
joint articular cartilage of STR/Ort and CBA mice at ages 8–
10 weeks, 18–20 weeks, and $40 weeks (n5 3 joints per strain
per age group), as previously described (22).
Multiplex quantitative reverse transcriptase–poly-
merase chain reaction (qRT-PCR). A GeXP multiplex qRT-
PCR assay was designed for the following gene targets: Ank,
Dmp1, Enpp1, Mepe, Opn (Spp1), Phex, and Sost (see Sup-
plementary Table 1, available on the Arthritis & Rheumatology
web site at http://onlinelibrary.wiley.com/doi/10.1002/art39508/
abstract). Target-specific reverse transcription was performed as
previously described (25,26), using 50 ng of total RNA.
Immunohistochemistry. Immunohistochemical analy-
sis was performed on 6-mm coronal sections using anti-sclerostin
antibody (1:100 dilution; R&D Systems), anti–matrix metallo-
proteinase (anti–MMP-13) antibody (1:200 dilution; Abcam),
anti-Col10a1 antibody (1:500 dilution; provided by Professor R.
Boot-Handford, University of Manchester), or anti-MEPE anti-
body (1:200 dilution; provided by Professor P. Rowe, University
of Kansas Medical Center, Kansas City, Kansas).
Articular cartilage and growth plate zone analysis.
Multiple toluidine blue–stained coronal sections (n5. 6) from
the joints of 4 individual mice per strain in each age group were
used to measure the width of joint compartments and growth
plate zones based on established cell morphology (27).
Joint imaging by micro–computed tomography (micro-
CT). Mouse joints were scanned using a laboratory source for
5m voxels and at a synchrotron for 1m voxels. The laboratory
scans were performed using a SkyScan 1172 x-ray microtomograph
to evaluate cortical and trabecular bone geometry. The synchro-
tron radiation microtomography was performed at Diamond Light
Source on the Diamond-Manchester Branchline I13-2 with projec-
tions being reconstructed and a procedure developed to character-
ize each individual bridge and map its location on the tibial joint
surface (28–30) (see Supplementary Methods, available on the
Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/
doi/10.1002/art39508/abstract).
Metatarsal organ cultures. Metatarsal bones (day 15
of embryogenesis) were cultured for up to 7 days (31,32). The
total length of the bone through the center of the mineralizing
zone and the length of the central mineralization zone were
determined using Image J software.
Sclerostin enzyme-linked immunosorbent assay (ELISA).
Serum sclerostin levels in CBA and STR/Ort mice at ages 8–10
weeks, 18–20 weeks, and $40 weeks (n5 4 for each strain at
each age) were measured using a mouse/rat sclerostin ELISA
kit (R&D Systems).
Statistical analysis. Data were analyzed by one-way
analysis of variance, Student’s t-test, or a suitable nonpara-
metric test using GraphPad Prism 6 and following normality
checks. All data are expressed as the mean6SEM.
RESULTS
Retention of calcified cartilage thickness despite
articular cartilage loss and subchondral bone thicken-
ing in STR/Ort mice. We first sought to determine tem-
porospatial patterns of changing joint architecture in
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STR/Ort mice. Consistent with previous findings (33),
we found that young STR/Ort mice had thicker medial
tibial articular cartilage than age-matched CBA controls
(P , 0.001). As STR/Ort mice aged, the medial tibial ar-
ticular cartilage became thinner, with concomitant
thickening of subchondral bone, neither of which oc-
curred in CBA mice (P , 0.001) (Figures 1A and B).
Despite this, there was no change in calcified cartilage
thickness in STR/Ort mice (Figure 1B), and further ana-
lysis revealed similar changes in the medial femur (see
Supplementary Figure 1, available on the Arthritis &
Rheumatology web site at http://onlinelibrary.wiley.com/
doi/10.1002/art39508/abstract). Lateral condyles in STR/
Ort mice were unaffected by such age-related structural
modifications. The lateral tibia also exhibited greater
articular cartilage thickness, possibly as compensation
for altered mechanical loads (see Supplementary Figure
1).
Transient chondrocyte behaviors in the articu-
lar cartilage of STR/Ort mice prior to OA onset. We
next examined whether the predisposition to age-related
subchondral bone thickening and loss of articular carti-
lage in STR/Ort mice with OA was linked to the
expression of markers of the transient chondrocyte phe-
notype. Initially, we used the DAVID functional anno-
tation clustering tool to identify biologic functions
enriched within differentially expressed genes in articu-
lar cartilage from mice with OA (STR/Ort mice ages
.18 weeks) compared to unaffected mice (CBA mice
ages 8–40 weeks and STR/Ort mice ages 8–10 weeks)
(22). Within the major gene ontology classifications,
there was significant up-regulation of endochondral bone
Figure 1. A and B, Thickness of uncalcified cartilage, calcified cartilage, and subchondral bone in the medial tibia of CBA mice (A) and STR/Ort
mice (B) at 8–10 weeks, 18–20 weeks, and $40 weeks of age. Ten measurements per section were obtained in .6 sections per mouse (n5 4 mice
per age group for each strain). Results are presented as the average percent of the thickness of each zone measured from articular surface to sub-
chondral bone. C–F, Immunolabeling for matrix metalloproteinase 13 (C and D) and for type X collagen (E and F) in the medial tibia (C and E)
and lateral tibia (D and F) of STR/Ort mice prior to the onset of osteoarthritis. Arrows indicate positive staining. Images are representative of
results in 3 individual mice. G and H, GeXP multiplex quantitative reverse transcription–polymerase chain reaction analysis of mRNA for Enpp1
(G) and Ank (H) in the articular cartilage of CBA and STR/Ort mice at 8–10 weeks, 18–20 weeks, and $40 weeks of age. Bars show the mean
6 SEM (n5 3 joints per sample; n5 3 samples per age group per strain). **5P , 0.01; ***5P , 0.001, versus CBA mice except where indicated
otherwise. Color figure can be viewed in the online issue, which is available at http://onlinelibrary.wiley.com/journal/doi/10.1002/art.39508/abstract.
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growth (P , 0.01) (Table 1 and Supplementary Table 2,
available on the Arthritis & Rheumatology web site at http://
onlinelibrary.wiley.com/doi/10.1002/art39508/abstract). No
gene ontology classifications associated with skeletal
development and ossification were found to be significantly
down-regulated.
These endochondral ossification gene ontologies
in STR/Ort mouse OA articular cartilage led us to exam-
ine protein expression of well-established chondrocyte
hypertrophy markers in OA development. Immunohisto-
chemistry demonstrated positive MMP-13 labeling in
both superficial and deep articular chondrocytes in the
joints of STR/Ort mice prior to OA onset (Figures 1C
and D). Consistent with previous findings (34), an
expected pattern of type X collagen expression was
observed in the unaffected condyles of STR/Ort mouse
joints, with immunolabeling restricted to hypertrophic
chondrocytes (Figure 1F). Intriguingly, type X collagen
immunolabeling was observed throughout the medial
condylar articular cartilage matrix in 8–10-week-old STR/
Ort mice, before histologically detectable OA (Figure
1E). Multiplex gene analysis of genes associated with
matrix mineralization confirmed significant elevation in
Enpp1 and Ank messenger RNA (mRNA) isolated from
articular cartilage from 8–10-week-old STR/Ort mice,
compared to CBA mice (P , 0.001) (Figures 1G and H).
Interestingly, these increases were diminished upon OA
onset (P , 0.01 for STR/Ort mice at 18–20 weeks versus
age-matched CBA mice for Enpp1) (Figures 1G and H).
These findings suggest that OA-prone regions of the
STR/Ort mouse cartilage exhibit an inherent instability
defect in articular chondrocytes.
Accelerated growth, dysfunctional growth plate
morphology, and matrix mineralization in STR/Ort
mice. To more fully define this inherent endochondral
chondrocyte defect, we examined the growth trajectories
of 1–8-week-old STR/Ort and CBA mice. We found
that STR/Ort mice weigh less than CBA mice (P ,
0.05) until 4–5 weeks of age, corresponding with the
attainment of sexual maturity, when they overtake CBA
mice (Figure 2A). Consistent with this finding, analysis
of embryonic longitudinal growth and mineralization in
vitro revealed aberrant rates of growth and endochon-
dral ossification in STR/Ort mouse metatarsal bones
(31,32) (Figures 2C–F), involving both a slowing of
metatarsal growth (Figure 2E) and marked reductions
in the mineralized portion of the element (Figure 2F).
Consistent with this accelerated growth phenotype,
STR/Ort mice also had shorter tibiae than CBA mice at 3
weeks of age (P , 0.05), which seemed to be reversed,
since tibia length at 6 weeks of age was not significantly dif-
ferent from that of CBA mice (Figure 2B). This was fur-
ther supported by comparisons of 8-week-old mice, when
the tibia was longer in STR/Ort mice than in age-matched
CBA mice (P , 0.01) (Figure 2B). Micro-CT analysis
showed significantly enhanced cortical and trabecular
parameters in 6-week-old STR/Ort mouse tibiae, with
higher percent differences in bone volume/total volume
(12%; P, 0.01), cortical thickness (23%; P, 0.05), corti-
cal area (23%; P, 0.001), polar moment of inertia (46%;
P, 0.05), trabecular pattern factor (27%; P , 0.05), and
structure model index (13%; P , 0.05) compared to age-
matched CBA mice (see Supplementary Table 3, avail-
able on the Arthritis & Rheumatology web site at http://
onlinelibrary.wiley.com/doi/10.1002/art39508/abstract). In
comparison, there were no significant differences at 3
weeks of age (Supplementary Table 3).
Growth plate zone analysis showed a significantly
enlarged proliferating zone of chondrocytes in both 3-
week-old and 6-week-old STR/Ort mice (P , 0.001 and
P , 0.05, respectively) (Figure 2G). This was not appar-
ent in 8-week-old STR/Ort mice when compared to age-
matched CBA mice (Figure 2G). Despite the lack of
any differences in the size of hypertrophic chondrocyte
zones, immunolabeling for type X collagen showed the
expected localization in CBA mouse growth plates, lim-
ited exclusively to the hypertrophic zone and underlying
metaphyseal bone at both 3 weeks and 6 weeks of age
(Figures 2H and I). In contrast, STR/Ort mice at both
ages showed considerably greater and more widely dis-
persed type X collagen expression, which extended addi-
tionally into the proliferative chondrocyte zone (Figures
2J and K). This disrupted distribution of growth plate
zone markers was also evident for MMP-13 in the
growth plates of STR/Ort mice (Figures 2L–O).
Link between OA in STR/Ort mice and modifi-
cations in the MEPE/sclerostin axis. Molecular mech-
anisms controlling endochondral ossification may help
identify those involved in OA. We have previously
shown MEPE, a member of the small integrin-binding
ligand N-linked glycoprotein (SIBLING) family, to be a
negative regulator of growth plate chondrocyte matrix
Table 1. Gene ontology analysis of genes up-regulated in osteoar-
thritic mouse articular cartilage compared to nonosteoarthritic
mouse articular cartilage*
Term % change P
Bone development 3.1 1.0 3 1025
Ossification 2.8 2.8 3 1025
Bone mineral formation 1.7 1.6 3 1024
Skeletal system development 4 3.4 3 1024
Cartilage development 1.7 6.10 3 1023
* Genes showing a change of .1.5 fold (n5 491) were analyzed with
DAVID.
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mineralization (31). Examination of MEPE expression
by multiplex analysis showed significantly higher levels
of Mepe mRNA in STR/Ort mouse articular cartilage
than CBA mouse articular cartilage (P , 0.001) (Figure
3A). Immunolabeling for MEPE showed differential
expression across the tibia of the STR/Ort mouse joints,
with a distinct lack of positive MEPE protein labeling in
the medial (affected) aspects both prior to and during
OA progression (Figure 3C). This is in contrast to the
lateral (unaffected) aspect of the STR/Ort mouse joints
and throughout all aspects of CBA mouse joints, where
labeling for MEPE was observed throughout the depth
of the articular cartilage tissue (Figures 3C and D).
Assessment of the MEPE regulator Phex revealed
elevated mRNA levels in articular cartilage from 8–10-
week-old STR/Ort mice compared to age-matched CBA
mice (P , 0.001) (Figure 3B). In STR/Ort mice, this
expression significantly decreased with OA onset (P ,
0.001 for STR/Ort mice at 18–20 weeks versus STR/Ort
mice at 8–10 weeks) (Figure 3B). Identical age-related
Figure 2. A,Weight of CBA and STR/Ort mice from 1 to 8 weeks of age (n5 5 or more mice per group). B, Length of the tibia in CBA and STR/Ort
mice at 3, 6, and 8 weeks of age (n5 6 mice per group). C and D, Digital images of metatarsal bones from STR/Ort mice on day 15 of embryogenesis
(C) and CBA mice (D) that were cultured for 7 days and measured. E and F,Growth rate (E) and percent change in mineralization zone (MZ) length
(F) of metatarsal bones of CBA and STR/Ort mice (n5 8 or more mice per group).G,Growth plate zone length in CBA and STR/Ort mice at 3, 6, and
8 weeks of age. Ten measurements per section were obtained in.6 sections per mouse (n5 4 mice per age group for each strain). PZ5proliferative
zone; HZ5 hypertrophic zone. H–K, Immunohistochemical analysis of type X collagen in a 3-week-old CBA mouse (H), a 6-week-old CBA mouse
(I), a 3-week-old STR/Ort mouse (J), and a 6-week-old STR/Ort mouse (K). L–O, Immunohistochemical analysis of MMP-13 in a 3-week-old CBA
mouse (L), a 6-week-old CBA mouse (M), a 3-week-old STR/Ort mouse (N), and a 6-week-old STR/Ort mouse (O). Images are representative of
results in 3 individual mice. Values in A, B, E, F, and G are the mean6 SEM. *5P, 0.05; **5P, 0.01; ***5P, 0.001. Original magnification3
10 inH–O. Color figure can be viewed in the online issue, which is available at http://onlinelibrary.wiley.com/journal/doi/10.1002/art.39508/abstract.
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expression patterns were found for Dmp1mRNA, another
SIBLING family member (P, 0.001) (Figure 3E). Analy-
sis of mRNA levels of osteopontin (Opn), a SIBLING
family member with shared roles in biomineralization,
showed significantly higher levels in aged STR/Ort mice
compared to young STR/Ort mice (P , 0.05) and age-
matched CBA mice (P , 0.05), resembling patterns of
Mepe expression (Figure 3F). Taken together, these find-
ings suggest a regulatory role for the SIBLING family of
proteins in OA development in these mice.
We next sought to examine the temporal expres-
sion of another important regulator of MEPE expres-
sion, the Wnt signaling inhibitor sclerostin (Sost) (35).
Our analyses showed greater levels of Sost mRNA in
articular cartilage from 8–10-week-old STR/Ort mice
than that from age-matched CBA mice (P , 0.05) (Fig-
ure 4A), with levels significantly decreasing with OA
onset (P , 0.01 for STR/Ort mice at 8–10 weeks versus
STR/Ort mice at 18–20 weeks) (Figure 4A). Despite
this, no differences in circulating serum sclerostin con-
centrations were observed in these mice at any age (Fig-
ure 4B), indicating solely local effects. Consistent with
this finding, sclerostin immunolabeling showed a clear
enrichment in cells at the osteochondral interface in
unaffected regions of STR/Ort mouse joints (Figure
4C). In contrast, STR/Ort mice with OA showed sup-
pression of positive sclerostin labeling of regions of sub-
chondral bone thickening underlying those with
compromised articular cartilage integrity (Figure 4D).
Link between premature growth plate closure
in STR/Ort mice and OA development. To directly test
whether longitudinal growth, growth plate fusion, and OA
exhibit interrelationships in STR/Ort mice, we developed a
novel protocol for quantifying bony bridges formed across
Figure 3. A and B, GeXP multiplex quantitative reverse transcription–polymerase chain reaction (qRT-PCR) analysis of mRNA for Mepe (A) and
Phex (B) in the articular cartilage of CBA and STR/Ort mice at 8–10 weeks, 18–20 weeks, and $40 weeks of age (n5 3 joints per sample; n5 3
samples per age group per strain). C, Immunohistochemical analysis of MEPE in the medial (affected) and lateral (unaffected) tibial condyles of
STR/Ort mice prior to and at the onset of osteoarthritis. D, Immunohistochemical analysis of MEPE in the tibial condyles of a CBA mouse. Images
are representative of results in 3 individual mice. E and F, GeXP multiplex qRT-PCR analysis of mRNA for Dmp1 (E) and Opn (F) in the articular
cartilage of CBA and STR/Ort mice at 8–10 weeks, 18–20 weeks, and $40 weeks of age (n5 3 joints per sample; n5 3 samples per age group per
strain). Bars in A, B, E, and F show the mean6 SEM. *5P , 0.05; ***5P , 0.001, versus CBA mice except where indicated otherwise. Color
figure can be viewed in the online issue, which is available at http://onlinelibrary.wiley.com/journal/doi/10.1002/art.39508/abstract.
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Figure 4. A, GeXP multiplex quantitative polymerase chain reaction
analysis of mRNA for Sost in the articular cartilage of CBA and STR/Ort
mice at 8–10 weeks, 18–20 weeks, and $40 weeks of age (n5 3 joints per
sample; n5 3 samples per age group per strain). B, Serum sclerostin lev-
els in CBA and STR/Ort mice at 8–10 weeks, 18–20 weeks, and $40
weeks of age (n5 4 mice per age group for each strain). Bars in A and B
show the mean6 SEM. C and D, Immunohistochemical analysis of scle-
rostin in the lateral (unaffected) tibial condyles (C) and medial (affected)
tibial condyles (D) in STR/Ort mice at the onset of osteoarthritis. Arrows
in C indicate sclerostin immunolabeling. Asterisk in D indicates subchon-
dral bone thickening. Images are representative of results in 3 individual
mice. Color figure can be viewed in the online issue, which is available at
http://onlinelibrary.wiley.com/journal/doi/10.1002/art.39508/abstract.
the entire murine tibia epiphysis during growth plate fusion
(see Supplementary Methods, available on the Arthritis &
Rheumatology web site at http://onlinelibrary.wiley.com/doi/
10.1002/art39508/abstract) (Figures 5A–C). Applying this
novel method to examine growth plate closure in STR/Ort
mice and CBA mice at 8 weeks of age and $40 weeks of
age revealed a dramatically (10-fold) greater total number
of bridges in 8-week-old STR/Ort mice (mean6 SEM
1376 10) than in CBA mice (mean6SEM 146 10) (P ,
0.001) (Figures 5D, E, and H) (see Supplementary Figure
2, available on the Arthritis & Rheumatology web site at http://
onlinelibrary.wiley.com/doi/10.1002/art39508/abstract). This
enriched growth plate bridging was apparent in all aspects of
STR/Ort mouse tibiae (P, 0.05) (Figure 5H). Although still
evident in aged STR/Ort mice ($40 weeks), the enriched
bone bridging was much less pronounced (mean6SEM
2956 72 in STR/Ort mice and 2666 53 in CBA mice) (Fig-
ures 5F, G, and I and Supplementary Figure 2). Mean areal
bridge densities were also greater in STR/Ort mice at both
ages (P , 0.01) (Figure 5J). These intriguing data reveal an
accelerated cartilage–bone transition in the growth plate
which, taken together with our findings described above, sup-
port the notion of an inherent endochondral defect in both
the articular and growth plate cartilage in STR/Ort mice.
DISCUSSION
Our data reveal changes in the articular cartilage
of STR/Ort mouse knee joints consistent with an aber-
rant deployment of endochondral processes. This is
associated with inherent longitudinal growth modifica-
tions, disrupted growth plate morphology, premature
growth plate fusion, and aberrant bone formation and
matrix mineralization prior to OA onset. These data
indicate that, at least in the spontaneous human-like
OA seen in STR/Ort mice, growth-related endochon-
dral ossification abnormalities may forecast mechanisms
of OA development in articular cartilage.
There are certainly some intriguing previously
published data on the expression of endochondral ossifi-
cation markers that support this notion (14). Type X col-
lagen is a marker of chondrocyte hypertrophy that is
usually found in the growth plate and is unique to the cal-
cified cartilage in normal joints (35). Expression of type
X collagen mRNA transcripts, as examined by in situ
hybridization, has, however, been observed throughout
articular cartilage in both young STR/Ort mice (at 9
weeks of age) and older STR/Ort mice (at $41 weeks of
age) (34). This is the first study to provide evidence of
associated type X collagen protein expression in these
mice. Consistent with our findings, an additional marker
of chondrocyte hypertrophy, MMP-13, has been detected
in the calcified cartilage chondrocytes of STR/Ort mice
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at both young and old ages, at levels greater than those in
age-matched CBA mice (37). Similarly, higher expression
levels of several other MMPs (MMP-2, MMP-3, MMP-7,
MMP-9, and membrane type 1 MMP) were observed in
the tibial articular chondrocytes of the STR/Ort mouse
(37). Indeed, many of these MMPs were also shown to
be significantly increased in our previous microarray
study, further highlighting their likely role as key players
in cartilage degradation in OA (22).
The STR/Ort mouse growth plate has remained
relatively unexamined with, to our knowledge, only one
published report describing phenotypic changes associ-
ated with aging. Chambers et al (34) describe type X
collagen mRNA expression localized to hypertrophic
chondrocytes, as expected, in both young CBA mice and
young STR/Ort mice. However, in the older mice, no
expression of type X collagen mRNA was observed,
despite the preservation of type II collagen mRNA
throughout the depth of the thinned growth plate cartilage
(34). The results of the present study indicate aberrant
expression of type X collagen and MMP-13 additionally in
the growth plate of young STR/Ort mice. STR/Ort mice
also display an increased zone of proliferative chondro-
cytes, based on well-established cell morphologic features
(27). These results may seem counterintuitive, but they
highlight the fact that there is clearly an inherent endo-
chondral defect in STR/Ort mice, which may also precipi-
tate OA pathogenesis.
Molecular mechanisms controlling endochondral
ossification may help identify those involved in OA.
Effective control of the Wnt signaling pathway is certain-
ly proving critical in regulating both the extent of OA
Figure 5. Development of a 3-dimensional quantification method for growth plate bridging. A, Three-dimensional representation of an entire
joint from an STR/Ort mouse at $40 weeks of age. B, Three-dimensional representation of the growth plate cartilage (yellow) underneath
the tibial joint surface (shown in gray in A). C, Three-dimensional representation of bridges crossing the growth plate underneath the tibial
joint. Crosses indicate bony bridges identified by an observer. D–G, Location and areal density of bridges across the growth plate projected
on the tibial joint surface in an STR/Ort mouse at 8 weeks of age (D), a CBA mouse at 8 weeks of age (E), an STR/Ort mouse at $40 weeks
of age (F), and a CBA mouse at $40 weeks of age (G). H and I, Number of bridges per tibia in CBA and STR/Ort mice at 8 weeks of age
(H) and $40 weeks of age (I). The lateral and medial segments and anterior and posterior segments were split in order to examine whether
bridging is balanced during fusion. J, Areal density (d) of bridges, defined as the number of bridges per 256 mm 3 256 mm window. Bars in
H–J show the mean6 SEM (n5 3 mice per group). *5P , 0.05; **5P , 0.01; ***5P , 0.001, versus CBA mice except where indicated
otherwise.
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joint pathology (38) and growth plate chondrocyte behav-
ior, and the data in the present study corroborate this.
Genetic and microarray analyses have been per-
formed in STR/Ort mice in order to better elucidate the
etiology of their OA (39–42). Jaeger and colleagues
identified a quantitative trait locus (QTL) associated
with articular cartilage degeneration on chromosome
8 of the STR/Ort mouse (39). This, however, was not
corroborated in a more recent QTL analysis in which
STR/Ort mice were backcrossed with the C57BL/6N
strain (43). This QTL was therefore suggested to be a
recessive trait among the polygenetic factors in OA in
STR/Ort mice (19,43). Instead, the authors identified a
QTL for the OA phenotype that is mapped to chromo-
some 4 (43). Chromosome 8 was, however, revisited,
and fine-mapping of the OA QTL in a more recent
study revealed Wnt-related genes associated with
altered chondrogenesis, including dickkopf 4 (Dkk4),
secreted Frizzled-related protein 1 (Sfrp1), and fibro-
blast growth factor 1 (Fgfr1) (38,42). While a number of
genes, including Wnt-related genes, have been implicat-
ed in OA by association studies in human populations,
there is a distinct lack of functional data to support a
causative link between these associated genes and OA.
Pasold et al attempted to find such a link and iden-
tified 23 polymorphic changes in the Sfrp1 gene in STR/
Ort mice in comparison to C57BL/6 mice (42). Further
immunohistochemical studies demonstrated that the
expression of secreted Frizzled-related protein 1 was
reduced in articular chondrocytes from young STR/Ort
mice, and this finding was confirmed by in vitro analysis
of STR/Ort mesenchymal stem cells (42). In the present
study, our meta-analysis of previous STR/Ort microarray
data did not reveal any significant changes in the gene
expression of Dkk4, Sfrp1, or Fgfr1. Instead, we found evi-
dence of the role of the Wnt inhibitor sclerostin in OA
development in STR/Ort mice. This is consistent with the
findings of other studies that have shown expression of
sclerostin in the articular cartilage of various species,
including mice and sheep (44,45). While we observed no
differences in serum sclerostin levels in STR/Ort mice, in
humans an inverse relationship with radiographic knee
OA severity has been observed, therefore implicating scle-
rostin as a potential biochemical marker (46).
This does not mean that the role of sclerostin in
OA is not controversial. Recent studies examining OA in
aged sclerostin-deficient mice and in rats treated with
sclerostin-neutralizing antibodies following surgical induc-
tion (45) concluded that genetic ablation of sclerostin
does not alter spontaneous age-dependent murine OA
development, nor does pharmacologic inhibition of scle-
rostin in a surgical model of OA (45). This therefore high-
lights the growing need for further investigation into the
precise role of sclerostin in this debilitating disease. This
may come from examining the role of its downstream
pathways; in this study we were interested in identifying
the role of one such novel pathway involving the
SIBLING protein MEPE (35). MEPE has been shown to
be a critical regulator of osteoblast and chondrocyte
matrix mineralization (12,31,47,48). The similarity in dif-
ferential patterns of MEPE and sclerostin expression that
we observed in STR/Ort mice implies a novel mechanism
by which sclerostin may function in OA. Alterations in
this pathway support the case for abnormal Wnt/b-cate-
nin signaling, as has been demonstrated in many studies
of OA, including in the STR/Ort mouse (42).
In endochondral growth, the Wnt pathway is
known to play an intricate and yet critical role, with
cartilage-specific b-catenin–deficient mice lacking typical
growth plate zones and exhibiting delayed endochondral
ossification (49). It has been shown that appropriate con-
trol of Wnt signaling in the growth plate is essential in
regulating proliferation, alignment, differentiation, hy-
pertrophy, and replacement of calcified matrix with bone
(38). During chondrogenesis, Wnt signaling is thought to
influence the cell–cell and cell–extracellular matrix inter-
actions upon which this fundamental process depends.
Various Wnt factors, including Wnt-3a, Wnt-6, Wnt-7a,
and many more, have been implicated as inhibitors of
chondrogenesis, while a similar number, including Wnt-
5a and Wnt-5b, have stimulatory roles (38).
Similar ambiguity applies to the role of Wnt signal-
ing in chondrocyte hypertrophic differentiation (38). In
particular, it has been shown that Wnt signaling regulates
the parathyroid hormone–related protein (PTHrP), Indian
hedgehog (IHH), and transforming growth factor b
(TGFb) feedback loop (49). Chondrocytes undergoing
hypertrophy secrete IHH, which acts upon the proliferat-
ing chondrocytes to maintain their proliferative state and
to restrict hypertrophy. IHH also stimulates TGFb pro-
duction, which in turn up-regulates PTHrP. This acts on
the prehypertrophic chondrocytes to prevent their further
differentiation and thus IHH production (50). This path-
way has also been implicated in OA, with increased IHH
expression reported in OA cartilage and selective IHH
deletion protecting against surgical OA progression
(51,52). While this pathway was not examined in the pre-
sent study, it would be interesting to investigate whether
sclerostin/MEPE regulates the PTHrP/IHH pathway in
STR/Ort mice and whether this contributes to their OA
pathology. Our data do, however, strengthen evidence of
the relationship between molecular dysregulation of the
Wnt/b-catenin pathway and endochondral growth defects.
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Whether the results presented here are unique
to OA in the STR/Ort mouse or are characteristic of
OA in general is an interesting consideration and one
that should be deliberated upon, as OA is being more
widely accepted as a clinicopathologic syndrome with
multiple etiologies. An elegant and comprehensive
microarray study by Bateman and colleagues (53) in
which gene expression profiling was performed in carti-
lage from wild-type mice with surgically induced OA
(destabilization of the medial meniscus [DMM]) at 1, 2,
and 6 weeks after surgery details the full list of differen-
tially expressed genes between mice with DMM OA and
sham-operated mice. Bateman et al found that levels of
the marker of hypertrophy MMP-13 were unchanged in
mice with DMM OA compared to sham-operated mice
at all stages after surgery (53). This contrasts with our
findings in STR/Ort mice, in which elevated MMP-13
expression levels were found prior to and during OA.
Consistent with our data, Bateman et al found Col10a1
to be significantly increased in mice with DMM OA
compared to sham-operated mice at 1 and 2 weeks after
surgery and the matrix mineralization regulators Enpp1
and Ank to be increased at all time points after surgery
(53). The differential expression of these matrix and
mineralization markers at early time points after surgery
suggests their involvement in the initial OA processes in
the DMM model. This is consistent with our data, which
show similar changes prior to OA development in STR/
Ort mice. Taken together, these findings suggest a point
of integration with these endochondral pathways at
which the different OA subtypes, surgical (DMM) and
natural (STR/Ort), may converge.
In this report, we highlight the MEPE/sclerostin
pathway as a potential pathway for future investigation
in OA research. Our data show differential expression
of MEPE and sclerostin in the STR/Ort mouse, along
with the MEPE regulator PHEX and other members of
the SIBLING family of proteins, DMP1 and osteopon-
tin. In the DMM model, none of these genes of interest
were dysregulated (53). Therefore, this subset of genes
is specific to STR/Ort mice with OA, and our identifica-
tion of this molecular phenotype not only will aid under-
standing of this diverse human condition, but also
suggests that we may be able to identify specific gene
signatures within particular at-risk human patients.
Our report of an inherent endochondral defect
in STR/Ort mice is further strengthened by our data
acquired using synchrotron x-ray computed microto-
mography that showed premature growth plate closure
in STR/Ort mice. This novel method for 3-dimensional
quantification of bony bridging will no doubt advance
understanding of growth plate closure mechanisms, and
our unique data revealing the complex internal topogra-
phies of the growth plate cartilage layer in CBA and
STR/Ort mice (Figures 5B and D) may also yield more
insights into the micro-mechanical environment of the
cells in the growth plate (54).
With this method we have demonstrated that OA-
prone STR/Ort mice and healthy CBA mice both display
overt bone bridges prior to growth cessation. More specif-
ically, spatial localization of these bridges has shown
greater clustering in STR/Ort mice, suggesting that their
formation is driven by local factors, likely altered mechan-
ical loading. The idea that OA in STR/Ort mice is driven
by loading has certainly been supported by the findings of
previous studies suggesting an association with medial
patellar dislocation (55) and by those showing accelerated
OA following mechanical joint loading (33). There have
also been direct links made between growth plate function
and mechanical loads, but whether this extends to the reg-
ulation of growth plate closure has yet to be explored
(56). Regardless, it remains clear that these studies have,
for the first time, shown that early growth plate closure is
indicative of modified growth trajectory in STR/Ort mice
and that growth ceases sooner in the lifetime of these
OA-prone mice than in the closely related parental CBA
strain, which shows healthy joint aging.
These data may also be interpreted as evidence
that the OA in STR/Ort mice is secondary to a chondro-
dysplasia. Data indicating internal rotation of the tibia
of STR/Ort mice may offer support for this notion (57).
However, the linked deployment of transient chondro-
cyte behaviors in the articular cartilage prior to overt
OA development that we observed suggests, instead,
that this reflects an inherent chondrocyte defect. None-
theless, the likelihood that such relationships with modi-
fied growth trajectories are also prevalent in human OA
is yet to be defined, and longitudinal studies examining
associations between growth plate dynamics and OA
development in human patients would be particularly
informative in our understanding of OA in general.
Despite the predictable disease development in
STR/Ort mice, with characteristics resembling those
seen in human OA, including osteophytes, subchondral
bone sclerosis, and synovial hyperplasia (19,20,58), the
insights into the etiology of OA provided by our data
from this mouse model are limited. For instance, the eti-
ology of OA in STR/Ort mice is not yet known, despite
extensive genetic and microarray analyses (39–41). As
such, there are potential factors that may confound
interpretation of our data, and it is vital to highlight that
our findings define only the distinct pathophysiologic
mechanisms important in this subset of OA. In addition,
the molecular phenotype we describe is unmodified in
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CBA mice, suggesting that the phenotype is disease spe-
cific, and indeed specific to OA in STR/Ort mice, as
opposed to any result of aging. It is still important, how-
ever, to consider the molecular phenotype of this partic-
ular OA, since it is becoming more widely accepted that
generalization of the OA disease in our pursuit of a
disease-modifying treatment is somewhat distracting
and flawed (59).
In conclusion, our findings show that aberrant
deployment of transient chondrocyte behaviors, consis-
tent with reinitiation of endochondral processes, occurs
in the joints of STR/Ort mice, which spontaneously
develop OA. Articular cartilage transcription profiles,
labeling for endochondral markers, and age-related
growth plate dynamics, both in vivo and in vitro, support
the notion that OA in STR/Ort mice is related to an
inherent endochondral growth defect that is subject to
regulation by the MEPE/sclerostin axis. Further investi-
gation will determine whether this is an underlying
mechanism in some or all forms of pathologic ossifica-
tion in OA.
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